Overall, about a third of semaglutide users achieved both inflammation reduction and scarring improvement, more than double those taking placebo, results show
Several other additives are commonly offered, each with a different theoretical justification
Semaglutide is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis, a serious condition resulting from untreated high blood sugar
The peptide demonstrates remarkable consistency in GH stimulation across diverse populations including children with growth hormone deficiency, healthy adults, and elderly subjects with age-related somatopause
It turns out that the thing that they picked, they can be both
JAMA Intern Med 179(5):633640